Skip to content
Cancer Institute NSW sites
eviQ Education
Learning resources for cancer staff
opens in a new tab or window
Cancer Institute NSW
NSW cancer control agency
opens in a new tab or window
Patient Information
Practical advice about cancer
opens in a new tab or window
Canrefer
Find a cancer specialist
opens in a new tab or window
BreastScreen NSW
Detect breast cancer early
opens in a new tab or window
Cervical Screening NSW
Cervical Screening NSW
opens in a new tab or window
iCanQuit
Learn how to quit smoking
opens in a new tab or window
Log in
Register
Search
Search
Log in
Register
Search
Main menu Toggle menu collaspe
Search eviQ
Close
Search
Search
Home
Home
Cancer genetics
Adult
Genetic testing for heritable pathogenic variants
Genetic testing using cancer gene panels
Risk management
Paediatric
Genetic testing for heritable pathogenic variants
Genetic testing using cancer gene panels
Risk management
Referral guidelines
Consumer information
Resources
Haematology and BMT
Leukaemias
Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Acute promyelocytic leukaemia
Chronic lymphocytic leukaemia
Chronic myeloid leukaemia
Hairy cell leukaemia
Myelodysplastic disorders
Lymphoma
Hodgkin lymphoma
Burkitt lymphoma
Mantle cell lymphoma
NK-cell and T-cell lymphoma
Other B-cell lymphoma
Primary CNS lymphoma
Waldenstrom macroglobulinaemia
Multiple myeloma
Blood and marrow transplant
Mobilisation
Allogeneic
Autologous
GVHD prophylaxis
Cellular therapies
Medical oncology
Breast
Neoadjuvant/Adjuvant
Metastatic
Colorectal
Adjuvant and neoadjuvant
Metastatic
Anal
Rectal
Gynaecological
Cervical
Endometrial
Gestational trophoblastic disease
Ovarian
Vulval
Head and neck
Definitive chemoradiation
Induction chemotherapy
Nasopharyngeal
Post operative chemoradiation
Recurrent or metastatic
Salivary gland
Thyroid
Neurological
Glioma
Respiratory
Mesothelioma
Non small cell lung cancer - Adjuvant/neoadjuvant
Non small cell lung cancer - Advanced/metastatic
Small cell lung cancer
Sarcoma
Soft tissue sarcoma
Bone sarcoma
Skin
Melanoma neoadjuvant/adjuvant
Melanoma metastatic
Non-melanoma
Upper gastrointestinal
Gastric and oesophageal adjuvant and neoadjuvant
Gastric and oesophageal metastatic
Gastrointestinal stromal cell tumours
Hepatic
Neuroendocrine
Pancreas and biliary
Urogenital
Adrenocortical
Bladder and Urothelial
Prostate
Renal
Testicular
Penile
Rare cancers
Colorectal
Gynaecological
Head and neck
Melanoma
Neurological
Respiratory
Sarcoma
Upper gastrointestinal
Urogenital
Tumour-agnostic
Tumour-agnostic
Radiation oncology
Breast
Colorectal
Gynaecological
Haematology
Head and neck
Neurological
Palliative
Respiratory
Upper gastrointestinal
Urogenital
Bladder
Prostate
Kidney and adrenal
Skin
Stereotactic
Clinical resources
eviQ calculators
Aboriginal health workers
ADDIKD guideline
Administration of anti-cancer drugs
Assessment tools
BMT & cellular therapies
Central venous access devices (CVADs)
Day of Treatment Assessment
Extravasation
Pumps
Health professional fact sheets
Oncological emergencies
Radiation oncology
Assessment tools
Cardiac implantable electronic devices
Contrast administration
Radiation-induced dermatitis
Side effect and toxicity management
Side effect and toxicity management
Cardiovascular
Gastrointestinal
General
Genitourinary
Gynaecological
Haematological
Hair, skin and nails
Immunological
Neurological and sensory
Oropharyngeal
Prophylaxis and treatment
Reproductive
Respiratory
Telephone triage toolkit
Patients and carers
Anticancer drug treatments
Radiation therapy treatments
Cancer genetics information sheets
Patient information sheets
At home
Cancer type specifics
Complementary and alternative medicines
Eating and drinking
Fertility, sex, pregnancy and breastfeeding
Treating cancer with medicines
How you have anticancer medicine treatment
Treating cancer with radiation therapy
Managing side effects
Vaccinations
Your family and friends
Patient information in other languages
عربى (Arabic)
简 (Simplified Chinese)
繁 (Traditional Chinese)
Français (French)
Ελληνικά (Greek)
Italiano (Italian)
한국어 (Korean)
Español (Spanish)
Tiếng Việt (Vietnamese)
Македонски (Macedonian)
ไทย (Thai)
Patient information videos
Cancer Institute NSW sites
eviQ Education
Learning resources for cancer staff
opens in a new tab or window
Cancer Institute NSW
NSW cancer control agency
opens in a new tab or window
Patient Information
Practical advice about cancer
opens in a new tab or window
Canrefer
Find a cancer specialist
opens in a new tab or window
BreastScreen NSW
Detect breast cancer early
opens in a new tab or window
Cervical Screening NSW
Cervical Screening NSW
opens in a new tab or window
iCanQuit
Learn how to quit smoking
opens in a new tab or window
Home
Haematology and BMT
Lymphoma
108 results
Search
Lymphoma bendamustine and rituximab
Lymphoma brentuximab vedotin
Lymphoma DHAP (dexamethasone cytarabine ciSplatin)
Lymphoma GDP (gemcitabine dexamethasone ciSplatin)
Lymphoma gemcitabine and vinORELBine
Zanubrutinib
Lymphoma GIVE (G-CSF iFOSFamide etoposide epirubicin) DISCONTINUED
Hodgkin lymphoma
Hodgkin lymphoma ABVD (DOXOrubicin bleomycin vinBLASTine dacarbazine) advanced stage
Hodgkin lymphoma ABVD (DOXOrubicin bleomycin vinBLASTine dacarbazine) early stage
Hodgkin lymphoma BEACOPDac escalated dose (bleomycin etoposide DOXOrubicin CYCLOPHOSPHamide vinCRISTine dacarbazine prednisolone)
Hodgkin lymphoma BEACOPP escalated dose (bleomycin etoposide DOXOrubicin CYCLOPHOSPHamide vinCRISTine procarbazine prednisolone)
Hodgkin lymphoma brentuximab vedotin
Hodgkin lymphoma BV-AVD (brentuximab vedotin DOXOrubicin vinBLASTine dacarbazine)
Hodgkin lymphoma BV-ICE (brentuximab vedotin fractionated iFOSFamide cARBOplatin etoposide)
Hodgkin lymphoma ChlVPP (chlorambucil vinBLASTine procarbazine prednisolone)
Hodgkin lymphoma DHAP (dexamethasone cytarabine ciSplatin)
Hodgkin lymphoma GDP (gemcitabine dexamethasone ciSplatin)
Hodgkin lymphoma gemcitabine and vinORELBine
Hodgkin lymphoma ICE (fractionated iFOSFamide cARBOplatin etoposide)
Hodgkin lymphoma IGEV (iFOSFamide gemcitabine vinORELBine prednisolone)
Hodgkin lymphoma PVAG (prednisolone vinBLASTine DOXOrubicin gemcitabine)
Pembrolizumab (flat dosing)
Hodgkin lymphoma ICE (infusional iFOSFamide cARBOplatin etoposide) SUPERSEDED
Hodgkin lymphoma BEACOPP standard dose (bleomycin etoposide DOXOrubicin CYCLOPHOSPHamide vinCRISTine procarbazine prednisolone) DISCONTINUED
Hodgkin lymphoma BEACOPP14 (bleomycin etoposide DOXOrubicin CYCLOPHOSPHamide vinCRISTine procarbazine prednisolone) DISCONTINUED
Hodgkin lymphoma GIVE (G-CSF iFOSFamide etoposide epirubicin) DISCONTINUED
Burkitt lymphoma
Burkitt lymphoma DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXOrubicin)
Burkitt lymphoma dose-modified R-CODOX-M and R-IVAC overview
GMALL 2002 overview (patients over 55 years)
GMALL 2002 overview (patients under 55 years)
Burkitt lymphoma dmCODOX-M/IVAC overview DISCONTINUED
Mantle cell lymphoma
Acalabrutinib
Mantle cell lymphoma ibrutinib
Mantle cell lymphoma R-BAC (rituximab, bendamustine, cytarabine)
Mantle cell lymphoma R-CHOP (rituximab CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Mantle cell lymphoma R-CHOP and R-DHAP overview
Mantle cell lymphoma R-DHAP (rituximab dexamethasone cytarabine ciSplatin)
Mantle cell lymphoma R-hyper CVAD overview
Mantle cell lymphoma rituximab maintenance
Mantle cell lymphoma R-maxi-CHOP and R-HiDAC and BEAM overview
Zanubrutinib
NK-cell and T-cell lymphoma
Cutaneous T-cell lymphoma vorinostat
Lymphoma brentuximab vedotin
Lymphoma GDP (gemcitabine dexamethasone ciSplatin)
Nelarabine
NK T-Cell lymphoma DDGP (dexamethasone ciSplatin gemcitabine pegaspargase)
NK T-Cell lymphoma modified SMILE (dexamethasone methotrexate iFOSFamide pegaspargase etoposide)
Non-Hodgkin lymphoma CHOEP14 (CYCLOPHOSPHamide DOXOrubicin vinCRISTine etoposide prednisolone)
Non-Hodgkin lymphoma CHOEP21 (CYCLOPHOSPHamide DOXOrubicin vinCRISTine etoposide prednisolone)
Non-Hodgkin lymphoma CHOP14 (CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Non-Hodgkin lymphoma CHOP21 (CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Peripheral T-cell lymphoma BV-CHP (brentuximab vedotin CYCLOPHOSPHamide DOXOrubicin prednisolone)
Peripheral T-cell lymphoma pralatrexate
Peripheral T-cell lymphoma romidepsin
NK T-Cell lymphoma SMILE (dexamethasone methotrexate iFOSFamide asparaginase etoposide) DISCONTINUED
Other B-cell lymphoma
Hairy cell leukaemia cladribine
Hairy cell leukaemia rituximab and cladribine
Lymphoblastic lymphoma hyper CVAD Part A and B/POMP overview
Lymphoma bendamustine and rituximab
Lymphoma Pembrolizumab (flat dosing)
Non-Hodgkin lymphoma bendamustine and oBINUTUZumab
Non-Hodgkin lymphoma bendamustine polatuzumab vedotin and rituximab
Non-Hodgkin lymphoma brentuximab vedotin
Non-Hodgkin lymphoma chlorambucil and rituximab
Non-Hodgkin lymphoma DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXOrubicin)
Non-Hodgkin lymphoma DHAC (dexamethasone cytarabine cARBOplatin)
Non-Hodgkin lymphoma DHAP (dexamethasone cytarabine ciSplatin)
Non-Hodgkin lymphoma ESHAP (etoposide methylprednisolone cytarabine ciSplatin)
Non-Hodgkin lymphoma GDP (gemcitabine dexamethasone ciSplatin)
Non-Hodgkin lymphoma gemcitabine and vinORELBine
Non-Hodgkin lymphoma glofitamab and oBINUTUZumab
Non-Hodgkin lymphoma hyper CVAD Part A and B overview
Non-Hodgkin lymphoma ICE (fractionated iFOSFamide cARBOplatin etoposide)
Non-Hodgkin lymphoma ICE (infusional iFOSFamide cARBOplatin etoposide)
Non-Hodgkin lymphoma idelalisib
Non-Hodgkin lymphoma oBINUTUZumab maintenance
Non-Hodgkin lymphoma O-CHOP21 (oBINUTUZumab CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Non-Hodgkin lymphoma O-CVP (oBINUTUZumab CYCLOPHOSPHamide vinCRISTine prednisolone)
Non-Hodgkin lymphoma Pola-R-CHP (polatuzumab vedotin rituximab CYCLOPHOSPHamide DOXOrubicin prednisolone)
Non-Hodgkin lymphoma R-CHOEP14 (rituximab CYCLOPHOSPHamide DOXOrubicin vinCRISTine etoposide prednisolone)
Non-Hodgkin lymphoma R-CHOP14 (rituximab CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Non-Hodgkin lymphoma R-CHOP21 (rituximab CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Non-Hodgkin lymphoma R-CVP (rituximab CYCLOPHOSPHamide vinCRISTine prednisolone)
Non-Hodgkin lymphoma R-DHAOx (rituximab dexamethasone cytarabine oxaliplatin)
Non-Hodgkin lymphoma R-DHAP (rituximab dexamethasone cytarabine ciSplatin)
Non-Hodgkin lymphoma R-GDP (rituximab gemcitabine dexamethasone ciSplatin)
Non-Hodgkin lymphoma R-GemOX (rituximab gemcitabine oxaliplatin)
Non-Hodgkin lymphoma RICE (rituximab fractionated iFOSFamide cARBOplatin etoposide)
Non-Hodgkin lymphoma RICE (rituximab infusional iFOSFamide cARBOplatin etoposide)
Non-Hodgkin lymphoma rituximab
Non-Hodgkin lymphoma rituximab maintenance
Non-Hodgkin lymphoma R-MiniCHOP (rituximab CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Non-Hodgkin Lymphoma SMARTE-R-CHOP14 (rituximab CYCLOPHOSPHamide DOXOrubicin vinCRISTine prednisolone)
Non-Hodgkin lymphoma tafasitamab and lenalidomide
Non-Hodgkin lymphoma rituximab maintenance subcutaneous SUPERSEDED
Non-Hodgkin lymphoma CVP (CYCLOPHOSPHamide vinCRISTine prednisolone) DISCONTINUED
Non-Hodgkin lymphoma CYCLOPHOSPHamide oral DISCONTINUED
Non-Hodgkin lymphoma GIVE (G-CSF iFOSFamide etoposide epirubicin) DISCONTINUED
Non-Hodgkin lymphoma PEN (prednisolone etoposide mitozantrone) DISCONTINUED
Non-Hodgkin lymphoma POMP maintenance therapy DISCONTINUED
Primary CNS lymphoma
Primary CNS lymphoma (PCNSL) MATRix (methotrexate cytarabine thiotepa and rituximab)
Primary CNS lymphoma (PCNSL) R-MPV/high dose cytarabine overview
Primary CNS lymphoma (PCNSL) high dose methotrexate SUPERSEDED
Primary CNS lymphoma (PCNSL) methotrexate and cytarabine SUPERSEDED
Primary CNS lymphoma (PCNSL) MBVP (methotrexate carmustine teniposide prednisolone) DISCONTINUED
Waldenstrom macroglobulinaemia
Waldenstrom macroglobulinaemia DRC (dexamethasone rituximab CYCLOPHOSPHamide)
Zanubrutinib
Waldenstrom macroglobulinaemia cladribine DISCONTINUED
Title
Content